The latest closing stock price for ArriVent BioPharma as of July 14, 2025 is 21.87.
An investor who bought $1,000 worth of ArriVent BioPharma stock at the IPO in 2024 would have $215 today, roughly 0 times their original investment - a 21.50% compound annual growth rate over 1 years.
The all-time high ArriVent BioPharma stock closing price was 35.63 on November 07, 2024.
The ArriVent BioPharma 52-week high stock price is 36.37, which is 66.3% above the current share price.
The ArriVent BioPharma 52-week low stock price is 15.47, which is 29.3% below the current share price.
The average ArriVent BioPharma stock price for the last 52 weeks is 24.32.
An investor who bought $1,000 worth of ArriVent BioPharma stock at the IPO in 2024 would have $215 today, roughly 0 times their original investment - a 21.50% compound annual growth rate over 1 years.
The all-time high ArriVent BioPharma stock closing price was 35.63 on November 07, 2024.
The ArriVent BioPharma 52-week high stock price is 36.37, which is 66.3% above the current share price.
The ArriVent BioPharma 52-week low stock price is 15.47, which is 29.3% below the current share price.
The average ArriVent BioPharma stock price for the last 52 weeks is 24.32.